It will take months for Russia to find ways to evade new U.S. sanctions. But if Iran can keep its energy exports flowing under heavy restrictions, Moscow probably can too. Brent crude rose by around ...

Representing Chicago’s West Side in the Illinois House of Representatives, I’ve seen firsthand how access to health care can be incredibly fragile for low-income families. Many of my constituents live ...

TOKYO, Oct 22 (Reuters) - As Japan's new premier Sanae Takaichi got to work on Wednesday, her government began finalising a purchase package, including U.S. pickups, soybeans and gas, to present to ...

From opening night to the NBA Finals, here's what to know about how to watch games in the 2025-26 season. Brian Martin The wait is over. Get ready for the start of the 2025-26 season. • Download the ...

WASHINGTON, Oct 15 (Reuters) - U.S. Treasury Secretary Scott Bessent on Wednesday said he plans to present three or four candidates to be the next leader of the Federal Reserve to President Donald ...

Google today announced Veo 3.1 as its latest video generation model, with Flow getting a number of updates to take advantage of the latest capabilities. Compared to Veo 3, which was announced at I/O ...

Google launched its new video model Veo 3.1 with improved audio output, granular editing controls, and better output for image to video. It said that Veo 3.1 builds on May’s Veo 3 release and ...

Poster 11: Literature Review: Acetylcholinesterase Inhibitors and Effects on Mortality in Alzheimer's Disease and Related Dementias Poster 12: Literature Review: Acetylcholinesterase Inhibitors and ...

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ...

Study Evaluates Antitumor Activity and Safety of REM-422, a First/Best-in-Class Small Molecule MYB mRNA Degrader, in Patients with Adenoid Cystic Carcinoma WATERTOWN, Mass., Oct. 13, 2025 (GLOBE ...

SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) ...